The Board proposes the rule amendment to clarify general anesthetic drugs employed on or administered to a patient by a dentist who possesses a valid general anesthesia permit issued by the Board and specifically to address the use of volatile gases ...  

  •  

    DEPARTMENT OF HEALTH

    Board of Dentistry

    RULE NO.: RULE TITLE:

    64B5-14.002: Prohibitions

    PURPOSE AND EFFECT: The Board proposes the rule amendment to clarify general anesthetic drugs employed on or administered to a patient by a dentist who possesses a valid general anesthesia permit issued by the Board and specifically to address the use of volatile gases as an anesthetic drug employed in the use of sedation.

    SUMMARY: General anesthetic drugs, specially volatile gases, prohibited in the use of sedation unless the dentist has a general anesthesia permit.

    SUMMARY OF STATEMENT OF ESTIMATED REGULATORY COSTS AND LEGISLATIVE RATIFICATION:

    The Agency has determined that this will not have an adverse impact on small business or likely increase directly or indirectly regulatory costs in excess of $200,000 in the aggregate within one year after the implementation of the rule. A SERC has not been prepared by the Agency.

    The Agency has determined that the proposed rule is not expected to require legislative ratification based on the statement of estimated regulatory costs or if no SERC is required, the information expressly relied upon and described herein: During discussion of the economic impact of this rule at its Board meeting, the Board, based upon the expertise and experience of its members, determined that a Statement of Estimated Regulatory Costs (SERC) was not necessary and that the rule will not require ratification by the Legislature. No person or interested party submitted additional information regarding the economic impact at that time.

    Any person who wishes to provide information regarding a statement of estimated regulatory costs, or provide a proposal for a lower cost regulatory alternative must do so in writing within 21 days of this notice.

    RULEMAKING AUTHORITY: 466.004(4), 466.017(3), 466.017(6) FS.

    LAW IMPLEMENTED: 466.017(3), 466.017(5) FS.

    IF REQUESTED WITHIN 21 DAYS OF THE DATE OF THIS NOTICE, A HEARING WILL BE SCHEDULED AND ANNOUNCED IN THE FAR.

    THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE IS: Jennifer Wenhold, Executive Director, Board of Dentistry, 4052 Bald Cypress Way, Bin #C08, Tallahassee, Florida 32399-3258.

     

    THE FULL TEXT OF THE PROPOSED RULE IS:

    64B5-14.002 Prohibitions.

    (1) through (7) No change.

    (8) The following general anesthetic drugs shall not be employed on or administered to a patient by a dentist unless the dentist possesses a valid general anesthesia permit issued by the Board pursuant to the requirements of this chapter: propofol, methohexital, thiopental, etomidate, or ketamine, or volatile gases (i.e., sevoflurane, isoflurane).

    (9) No change.

    Rulemaking Authority 466.004(4), 466.017(3), 466.017(6) FS. Law Implemented 466.017(3), 466.017(5) FS. History–New 1-31-80, Amended 4-20-81, 2-13-86, Formerly 21G-14.02, 21G-14.002, Amended 12-20-93, Formerly 61F5-14.002, Amended 8-8-96, Formerly 59Q-14.002, Amended 3-9-03, 11-4-03, 6-15-06, 12-25-06, 12-11-11, 8-5-12, 12-15-14,                        .

     

    NAME OF PERSON ORIGINATING PROPOSED RULE: Board of Dentistry

    NAME OF AGENCY HEAD WHO APPROVED THE PROPOSED RULE: Board of Dentistry

    DATE PROPOSED RULE APPROVED BY AGENCY HEAD: November 20, 2015

    DATE NOTICE OF PROPOSED RULE DEVELOPMENT PUBLISHED IN FAR: January 15, 2016

     

Document Information

Comments Open:
2/2/2016
Summary:
General anesthetic drugs, specially volatile gases, prohibited in the use of sedation unless the dentist has a general anesthesia permit.
Purpose:
The Board proposes the rule amendment to clarify general anesthetic drugs employed on or administered to a patient by a dentist who possesses a valid general anesthesia permit issued by the Board and specifically to address the use of volatile gases as an anesthetic drug employed in the use of sedation.
Rulemaking Authority:
466.004(4), 466.017(3), 466.017(6) FS.
Law:
466.017(3), 466.017(5) FS.
Contact:
Jennifer Wenhold, Executive Director, Board of Dentistry, 4052 Bald Cypress Way, Bin #C08, Tallahassee, Florida 32399-3258.
Related Rules: (1)
64B5-14.002. Prohibitions